News | Sudden Cardiac Arrest | June 26, 2017

Cedars-Sinai Team Develops New Sudden Cardiac Arrest Risk Assessment Score

Risk is calculated using cost-effective, noninvasive and widely available 12-lead EKG data

Cedars-Sinai Team Develops New Sudden Cardiac Arrest Risk Assessment Score

June 26, 2017 — A Cedars-Sinai Heart Institute investigator and his team have developed a new risk assessment tool that brings physicians closer to predicting who is most likely to suffer a sudden cardiac arrest.

Sudden cardiac arrest, an electrical disturbance in the heart rhythm that causes the heart to stop beating, can be prevented sometimes – if there is a way to determine who is likely to have one so that appropriate medical treatment is administered in time.

“For most people who have a sudden cardiac arrest, it is too late for them by the time 911 is called,” said the study’s senior author, Sumeet Chugh, M.D., director of the Heart Rhythm Center at the Cedars-Sinai Heart Institute in Los Angeles. “Because so few survive, it’s crucial for us to predict which patients are most vulnerable. This new risk score gives us a better idea of who is most likely to have cardiac arrest. Best of all, it is broadly accessible. It uses widely available and very inexpensive technology.”

The new risk score from Chugh and his team is based on readings from a 12-lead electrocardiogram (EKG) test — the oldest and least expensive cardiac test available. Their findings, published in European Heart Journal, show how the researchers calculated patients’ risk scores using multiple data points from a patient’s EKG. Data points include the patient’s heart rate, left ventricular hypertrophy (thickening of the walls of the heart), and four specific measures of how the heart muscle undergoes electrical stimulation and relaxation. Patients determined to be at high risk for sudden cardiac arrest can be pre-emptively treated with medication and by implanting a defibrillator that can shock a stopped heart into beating.

Patients’ scores range from zero to 6. Patients scored at 4 or above have as much as 20 times the increased risk for sudden cardiac arrest as patients with lower scores. 

More than 350,000 out-of-hospital cardiac arrests occur annually in the United States, and the condition is fatal in more than 90 percent of patients. Although the terms “sudden cardiac arrest” and “heart attack” often are used interchangeably, the conditions are different. A sudden cardiac arrest is an electrical disturbance in the heart rhythm that causes the heart to stop beating, and usually causes death immediately. A heart attack is caused when one of the major arteries leading to the heart becomes clogged, usually with plaque, disrupting the flow of blood to the heart muscle.

Because of the major public health implications of sudden cardiac death, finding a better means of identifying individuals at high risk has been a priority for the medical community. The currently available method to assess risk of sudden cardiac arrest is based on measurement of the left ventricular ejection fraction (LVEF), which measures how effectively the heart is pumping blood. Patients with LVEF value below 35 percent are deemed to be at high risk. However, this method has not been found to be effective and also does not help those with LVEF over 35 percent, who happen to be the majority of patients who suffer sudden cardiac arrest. The study found that the EKG-based score worked for patients at all levels of LVEF measurement and was especially effective among patients with LVEF over 35 percent.

“This new risk score has the potential to provide clinicians with a user-friendly, inexpensive, data-driven tool for determining which of their patients could benefit from interventions to prevent sudden cardiac arrest,” Chugh said.

Doctors may use the score to determine which patients will benefit most from interventions such as the implantable cardioverter-defibrillator, a device that can be surgically placed in the body to restore the heartbeat lost during sudden cardiac arrest within seconds by delivering a timely electrical shock.

The findings came out of a larger research enterprise called the Oregon Sudden Unexpected Death Study, an ongoing, comprehensive assessment of all sudden cardiac arrests in the Portland, Ore., metropolitan area, home to 1 million people. The study, founded and led by Chugh, has been underway for more than 15 years. Data collected from it provides Chugh and his team with unique, community-based information to mine for answers to what causes sudden cardiac arrest.

Researchers analyzed a unique resource of 522 patients who suffered sudden cardiac arrest, who also had archived 12-lead EKG readings available before and unrelated to the lethal event. They were compared with 736 geographical control patients to discover and assess the effectiveness of the new risk score. The risk score was then successfully validated in the Atherosclerosis Risk in Communities Study, a separate U.S. cohort of patients that also tracks those who experience sudden cardiac arrest. The novel risk score is now ready for further prospective clinical evaluation, Chugh said.

The National Heart, Lung, and Blood Institute funded the study (grant numbers R01HL122492 and R01HL126938 to Sumeet Chugh, M.D.).

For more information: www.academic.oup.com/eurheart

Related Content

HHS Releases Second Edition of Physical Activity Guidelines for Americans
News | Cardiac Diagnostics | November 14, 2018
The U.S. Department of Health and Human Services (HHS) released the second edition of the Physical Activity Guidelines...
ACC and AHA Release Updated Cholesterol Guidelines for 2018. #AHA18 #AHA2018
Feature | Cardiac Diagnostics | November 13, 2018
November 13, 2018 — New cholesterol guidelines from the American Heart Association (AHA) and the American College of
AMI READMITS Score Predicts Heart Attack Patients at High Readmission Risk
News | Cardiac Diagnostics | October 09, 2018
Tracking just seven factors of heart attack patients when they are first admitted to the hospital can help flag those...
Siemens Healthineers Showcases New In Vivo and In Vitro Cardiovascular Solutions at TCT 2018
News | Cardiac Diagnostics | September 21, 2018
At the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference, Sept. 21-25 in San Diego, Siemens Healthineers...
Weight Loss Drug Does Not Increase Cardiovascular Events
News | Cardiac Diagnostics | August 31, 2018
A weight loss drug does not increase cardiovascular events, according to late breaking results from the CAMELLIA-TIMI...
Acarix Presents CADScor System at ESC 2018
News | Cardiac Diagnostics | August 27, 2018
Acarix AB’s ultra-sensitive acoustic CADScor System for coronary artery disease risk assessment will be on display at...
NIH Ending Funding for Moderate Alcohol and Cardiovascular Health Trial
News | Cardiac Diagnostics | August 24, 2018
The National Institutes of Health announced in June it plans to end funding to the Moderate Alcohol and Cardiovascular...
Study Shows Multiple Benefits of Patient-to-Patient Connectivity in Familial Chylomicronemia Syndrome
News | Cardiac Diagnostics | August 07, 2018
Akcea Therapeutics Inc., an affiliate of Ionis Pharmaceuticals Inc., announced the publication of results from the...
Being Overweight May Change Young Adults' Heart Structure, Function
News | Cardiac Diagnostics | August 03, 2018
Even as a young adult, being overweight may cause higher blood pressure and thicken heart muscle, setting the stage for...
Overlay Init